Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Last Name

profileDonna Felsenstein, M.D.

TitleAssistant Professor of Medicine
InstitutionMassachusetts General Hospital
AddressMassachusetts General Hospital
Infectious Disease Unit, Gray-5
55 Fruit St
Boston MA 02114
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, Peterson DL, Gottschalk CG, Schultz AF, Che X, Eddy ML, Komaroff AL, Lipkin WI. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015 Feb; 1(1). PMID: 26079000.
    View in: PubMed
  2. Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, Hayden D, Shui A, Brooks B, Conwit R, Felsenstein D, Greenblatt DJ, Keroack M, Kissel JT, Miller R, Rosenfeld J, Rothstein JD, Simpson E, Tolkoff-Rubin N, Zinman L, Shefner JM. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014 Nov; 13(11):1083-1091. PMID: 25297012; PMCID: PMC4216315.
  3. Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013; 8(4):e61177. PMID: 23613806; PMCID: PMC3629222.
  4. Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis. 2010 Nov 15; 202(10):1478-81. PMID: 20936980; PMCID: PMC2957553.
  5. Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, Papaliodis GN, Durand ML, Felsenstein D. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect. 2011 Feb; 87(1):4-8. PMID: 20798396; PMCID: PMC3103105.
  6. Li JZ, Tucker JD, Lobo AM, Marra CM, Davis BT, Papaliodis GN, Felsenstein D, Durand ML, Yawetz S, Robbins GK. Ocular syphilis among HIV-infected individuals. Clin Infect Dis. 2010 Aug 15; 51(4):468-71. PMID: 20604717; PMCID: PMC2928476.
  7. Ryan ET, Felsenstein D, Aquino SL, Branda JA, Morgan JG. Case records of the Massachusetts General Hospital. Case 39-2005. A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophilia. N Engl J Med. 2005 Dec 22; 353(25):2697-705. PMID: 16371636.
    View in: PubMed
  8. Carr PL, Rothberg MB, Friedman RH, Felsenstein D, Pliskin JS. "Shotgun" versus sequential testing. Cost-effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med. 2005 Sep; 20(9):793-9. PMID: 16117745; PMCID: PMC1490200.
  9. Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998 May; 13(5):335-46. PMID: 9613891; PMCID: PMC1496957.
  10. Moran JS, Kaufman JA, Felsenstein D. Survey of health care providers: who sees patients needing STD services, and what services do they provide? Sex Transm Dis. 1995 Jan-Feb; 22(1):67-9. PMID: 7709328.
    View in: PubMed
  11. Brewer TF, Wilson ME, Gonzalez E, Felsenstein D. Bacon therapy and furuncular myiasis. JAMA. 1993 Nov 03; 270(17):2087-8. PMID: 8411575.
    View in: PubMed
  12. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987 Jun 18; 316(25):1569-72. PMID: 3587290.
    View in: PubMed
  13. D'Amico DJ, Talamo JH, Felsenstein D, Hirsch MS, Albert DM, Schooley RT. Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U. Arch Ophthalmol. 1986 Dec; 104(12):1788-93. PMID: 3024605.
    View in: PubMed
  14. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12; 313(24):1493-7. PMID: 2999591.
    View in: PubMed
  15. Plotkin SA, Drew WL, Felsenstein D, Hirsch MS. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J Infect Dis. 1985 Oct; 152(4):833-4. PMID: 2995505.
    View in: PubMed
  16. Felsenstein D, D'Amico DJ, Hirsch MS, Neumeyer DA, Cederberg DM, de Miranda P, Schooley RT. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Ann Intern Med. 1985 Sep; 103(3):377-80. PMID: 2992334.
    View in: PubMed
  17. Felsenstein D, Carney WP, Iacoviello VR, Hirsch MS. Phenotypic properties of atypical lymphocytes in cytomegalovirus-induced mononucleosis. J Infect Dis. 1985 Jul; 152(1):198-203. PMID: 2989382.
    View in: PubMed
  18. Hirsch MS, Wormser GP, Schooley RT, Ho DD, Felsenstein D, Hopkins CC, Joline C, Duncanson F, Sarngadharan MG, Saxinger C, et al. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med. 1985 Jan 03; 312(1):1-4. PMID: 2981106.
    View in: PubMed
  19. Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle W, Weitzman S. Antineutrophil antibodies in infectious mononucleosis. Am J Med. 1984 Jan; 76(1):85-90. PMID: 6318560.
    View in: PubMed
  20. Hirsch MS, Felsenstein D. Cytomegalovirus-induced immunosuppression. Ann N Y Acad Sci. 1984; 437:8-15. PMID: 6100012.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at For faculty personal and demographic information, contact HMS Office for Faculty Affairs at
Felsenstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
Co-Authors Expand Description
Similar People Expand Description
Same Department Expand Description
Physical Neighbors Expand Description